Overview
Updated 14 Jul 2026
Bradley J. Monk, MD, is Medical Director, Late-Phase Clinical Research at Florida Cancer Specialists & Research Institute (West Palm Beach, Good Samaritan/Flagler). The public record shows 1,001 publications with 45,442 citations (h-index 94), centered on Ovarian cancer diagnosis and treatment, Endometrial and Cervical Cancer Treatments, PARP inhibition in cancer therapy. It also documents an investigator role on 18 registered clinical trials, industry payments reported by 58 companies.
- Most recent indexed publication: 2026 · JCO precision oncology
- Top research focus: Ovarian cancer diagnosis and treatment
- 18 registered trials on ClinicalTrials.gov
- Open Payments reporting from 58 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 41 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 422.
Clinical & industrytrials, payments and federal funding
Federally funded research awards.
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 18 registered studies on ClinicalTrials.gov. The most recent:
- A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Sponsor: Eli Lilly and Company
InvestigatorPhase 3RecruitingNCT07213804 - A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
Sponsor: Verastem, Inc.
InvestigatorPhase 3RecruitingNCT06072781 - ONC-392 and Pembrolizumab in Platinum Resistant Ovarian Cancer
Sponsor: OncoC4, Inc.
InvestigatorPhase 2Active, not recruitingNCT05446298
Industry payments
Updated 14 Jul 2026
58 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- GlaxoSmithKline, LLC.Program year202544 payments$77,418openpaymentsdata.cms.gov ↗
- Merck Sharp & Dohme LLCProgram year202564 payments$64,654openpaymentsdata.cms.gov ↗
- Takeda Pharmaceuticals U.S.A., Inc.Program year20255 payments$46,802openpaymentsdata.cms.gov ↗
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Gemogenovatucel-T Advantage in Clonal Tumor Mutation Burden-High Ovarian Cancer.
JCO precision oncology
2026 - Decoding the End Points of Poly (ADP-ribose) Polymerase Inhibitor Trials in Ovarian Cancer.
Journal of clinical oncology
2025
Most-cited worksby citation count (OpenAlex)
- 01
- 02Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer2,386 citations2011
- 03
- 04Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer2,265 citations2019
- 05Improved Survival with Bevacizumab in Advanced Cervical Cancer1,502 citations2014
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →media.mycme.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →media.mycme.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →media.mycme.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
- Fellowship
Gynecologic Oncology, MD Anderson Cancer Center, Houston
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →flcancer.com ↗ - Fellowship
Medical Genetics, National Institutes of Health, Bethesda
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →flcancer.com ↗ - Board-certified
Gynecologic Oncology (FACOG, FACS)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →flcancer.com ↗
Editorial & leadership rolesjournal and society appointments
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →media.mycme.com ↗
- Cervical Cancer Sub-Committee Chair
NRG Oncology (11 years)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →media.mycme.com ↗ - Prior Chair
Cervical Cancer Committee, Gynecologic Cancer Intergroup
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →media.mycme.com ↗
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →flcancer.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →flcancer.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →flcancer.com ↗
Secondary affiliationsappointments beyond the home institution
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →media.mycme.com ↗
- Prior: Associate Professor
Division of Gynecologic Oncology, Chao Family Comprehensive Cancer Center, UC Irvine Medical Center (1998-2010); Director of Research, Dept. of OB/GYN
2010verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →media.mycme.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →media.mycme.com ↗
Media & interviewspress, podcasts and appearances
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →emjreviews.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/bradley-monk-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/bradley-j-monk-md-4879a7155
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
Mentions by otherswhere others cite or feature them
- Other
videopodcast.researchtopractice.com/ovarian-cancer-bradley-j-monk-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →videopodcast.researchtopractice.com ↗ - Other
emjreviews.com/oncology/congress-review/esgo-2025-insights-an-interview-with-bradley-monk
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →emjreviews.com ↗ - Facebook
facebook.com/FloridaCancerSpecialists/posts/were-proud-to-share-that-dr-bradley-monk-fcs-board-certified-gynecologic-oncolog/1389543439838593
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Coleman, MD
Texas Oncology
- 1,362
- publications
- 105
- h-index
- 16
- trials
Kathleen Moore, MD
University of Nebraska at Omaha
- 1,026
- publications
- 84
- h-index
- 21
- trials
Carol Aghajanian, MD
Memorial Sloan Kettering Cancer Center
- 849
- publications
- 88
- h-index
- 11
- trials
Richard Penson, MD
Massachusetts General Hospital
- 394
- publications
- 68
- h-index
- 9
- trials